Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2005-07-12
2005-07-12
Berch, Mark L. (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C544S364000, C544S360000, C514S253110, C514S253130
Reexamination Certificate
active
06916817
ABSTRACT:
Arylpiperazines of Formula I useful as metalloproteinase inhibitors, especially as MMP13 inhibitors.
REFERENCES:
patent: 5817822 (1998-10-01), MacPherson et al.
patent: 198 02 350 (1998-07-01), None
patent: WO 99/02510 (1999-01-01), None
patent: WO 99/18074 (1999-04-01), None
patent: WO 99/38843 (1999-08-01), None
patent: WO 00/12478 (2000-03-01), None
Coussens et al. {SCIENCE, vol. 295, Mar. 29, 2002}.
AstraZeneca AB
Berch Mark L.
Habte Kahsay
Pillsbury & Winthrop LLP
LandOfFree
Inhibitors of metalloproteinases does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Inhibitors of metalloproteinases, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibitors of metalloproteinases will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3375919